There are 9 papers on PSA density in aging research: 8 observational studies in people, 1 review.
9 papers study it7 more mention it7 findings
1 new paper in 30 daysSee all 16 papers on PSA density
“PSA density (HR, 1.41; 95% CI, 1.30-1.52) remained consistently associated with prostate cancer risk”
- Humans8
Effects
1Age
no changein humans1
1 study
Age
no changein humans1
PSA density was not clearly linked with age in humans (biopsy-negative Chinese men) (r = -0.032).
“PSAD did not (r = -0.032, p = 0.465)”
Humansbiopsy-negative Chinese menmalesn = 528
Cancer medicine
Associations
4Prostate cancer
upin humans3OR 1.095–3.02
3 studies
Prostate cancer
upin humans3OR 1.095–3.02
PSA density is associated with prostate cancer in humans after propensity score matching in BPH patients undergoing HoLEP (OR 1.095, 95% CI 1.04-1.16, p=0.01).
“elevated preoperative prostate-specfic antigen (PSA) density was significantly associated with the presence of iPCa (odds ratio [OR] 1.095, 95% confidence interval [CI] 1.04-1.16, p=0.01).”
Humansafter propensity score matching in BPH patients undergoing HoLEP
Rates of incidental prostate cancer following HoLEP Can it be predicted preoperatively?
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
PSA density predicts prostate cancer in humans (men with PSA levels of 4-10 ng/mL) (aOR = 1.81; 95% CI: 1.20-3.18; p = 0.013).
“PSA density (aOR = 1.81; 95% CI: 1.20-3.18; p = 0.013) were independent predictors of csPCa”
Humansmen with PSA levels of 4-10 ng/mLn = 286
BioMed research international
PSA density raises the risk of prostate cancer in humans (OR: 3.02; 95% CI: 1.50-6.07; p = 0.01).
“PSA density >0.15 ng/mL/cc (OR: 3.02; 95% CI: 1.50-6.07; p = 0.01)”
Review
Prostate cancer and prostatic diseases
Chinese ethnicity
upin humans1
1 study
Chinese ethnicity
upin humans1
Chinese ethnicity is associated with PSA density in humans (men without PCa compared to AA and CA men) (0.28 vs. 0.19 vs. 0.11 ng/mL/mL).
“PSAD: 0.28 vs. 0.19 vs. 0.11 ng/mL/mL, p < 0.001”
Humansmen without PCa compared to AA and CA menmales
Cancer medicine
Incidental prostate cancer
upin humans1
1 study
Incidental prostate cancer
upin humans1
PSA density predicts incidental prostate cancer in humans (Men undergoing surgery for benign prostatic hyperplasia) (AUC 0.86 for PSAD versus 0.80 for PSA).
“PSAD discriminated iPCa better than PSA (AUC 0.86 vs 0.80).”
HumansMen undergoing surgery for benign prostatic hyperplasiaprostatemalesn = 735
Incidental prostate cancer following surgery for benign prostatic hyperplasia: a cohort study
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
Prostate cancer incidence
upin humans1HR 1.41
1 study
Prostate cancer incidence
upin humans1HR 1.41
PSA density is associated with prostate cancer incidence in humans (without prostate cancer at baseline) (HR 1.41, 95% CI 1.30-1.52).
“PSA density (HR, 1.41; 95% CI, 1.30-1.52) remained consistently associated with prostate cancer risk”
Humanswithout prostate cancer at baseline20 yearsmalesn = 2,651
Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years
JAMA network open